U.S., Sept. 4 -- ClinicalTrials.gov registry received information related to the study (NCT07151729) titled 'Use of Anodal tDCS to Enhance Upper Limb Recovery in Stroke' on Aug. 08.
Brief Summary: This will be a randomized, blinded, sham-controlled trial. The medical device used, Soterix Medical 1x1 tDCS stimulator, is capable of delivering either real or sham tDCS and has been used in many randomised controlled trials in stroke patients.
50 patients with subacute stroke and severe upper limb weakness within 8 weeks of stroke on transfer to TTSH stroke rehab wards will be recruited over a period of 10 months. Recruited patients will be randomized into the intervention and control arms in a 1:1 ratio.
Study Start Date: Sept. 01
Study Typ...